🇺🇸 FDA
Patent

US 10034916

Methods of treating a retinal disease by retinal pigment epithelial stem cells

granted A61KA61K38/1825A61P

Quick answer

US patent 10034916 (Methods of treating a retinal disease by retinal pigment epithelial stem cells) held by REGENERATIVE RESEARCH FOUNDATION expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERATIVE RESEARCH FOUNDATION
Grant date
Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/1825, A61P, A61P25/00, A61P27/02